Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis.

MLA

Carcao, Manuel, et al. “Real‐world Data of Immune Tolerance Induction Using Recombinant Factor VIII Fc Fusion Protein in Patients with Severe Haemophilia A with Inhibitors at High Risk for Immune Tolerance Induction Failure: A Follow‐up Retrospective Analysis.” Haemophilia, vol. 27, no. 1, Jan. 2021, pp. 19–25. EBSCOhost, https://doi.org/10.1111/hae.14192.

APA

Carcao, M., Shapiro, A., Hwang, N., Pipe, S., Ahuja, S., Lieuw, K., Staber, J. M., Belletrutti, M., Sun, H. L., Ding, H., Wang, M., Price, V., Steele, M., Tsao, E., Feng, J., Al, K. Z., Dumont, J., & Jain, N. (2021). Real‐world data of immune tolerance induction using recombinant factor VIII Fc fusion protein in patients with severe haemophilia A with inhibitors at high risk for immune tolerance induction failure: A follow‐up retrospective analysis. Haemophilia, 27(1), 19–25. https://doi.org/10.1111/hae.14192

Chicago

Carcao, Manuel, Amy Shapiro, Nina Hwang, Steven Pipe, Sanjay Ahuja, Ken Lieuw, Janice M. Staber, et al. 2021. “Real‐world Data of Immune Tolerance Induction Using Recombinant Factor VIII Fc Fusion Protein in Patients with Severe Haemophilia A with Inhibitors at High Risk for Immune Tolerance Induction Failure: A Follow‐up Retrospective Analysis.” Haemophilia 27 (1): 19–25. doi:10.1111/hae.14192.